【Adimmune Corporation】Q1 2026 EPS -NT$0.44
Key facts
- 【Adimmune Corporation】Q1 2026 EPS -NT$0.44
- Adimmune Corporation, a company in the biotechnology and medical care industry, announced its financial results for the first quarter of 2026, reporting a basic earnings per share of -NT$0.44, operating revenue of NT$82 million, and a net loss of NT$200 million.
- Source: PR Times
- Date: March 1, 2026
Direct answer
Adimmune Corporation, a company in the biotechnology and medical care industry, announced its financial results for the first quarter of 2026, reporting a basic earnings per share of -NT$0.44, operating revenue of NT$82 million, and a net loss of NT$200 million.
- Citation
- 【Adimmune Corporation】Q1 2026 EPS -NT$0.44 (March 1, 2026), PR Times
- Source
- PR Times
- Date
- March 1, 2026
Adimmune Corporation, a company in the biotechnology and medical care industry, announced its financial results for the first quarter of 2026, reporting a basic earnings per share of -NT$0.44, operating revenue of NT$82 million, and a net loss of NT$200 million.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: May 15, 2026 at 08:01 (1799h 1m after Published)
- 🤖 AI Analyzed: May 15, 2026 at 19:26 (11h 24m after Collected)
Company Name: Adimmune Corporation
Industry: Biotechnology and Medical Care
Year/Quarter: 2026 Q1
Basic Earnings Per Share: -NT$0.44
Operating Revenue: NT$82 million
Net Profit After Tax: -NT$200 million
FAQ
What are the key facts in this article?
Adimmune Corporation, a company in the biotechnology and medical care industry, announced its financial results for the first quarter of 2026, reporting a basic earnings per share of -NT$0.44, operating revenue of NT$82 million, and a net loss of NT$200 million.
What is the direct answer?
Adimmune Corporation, a company in the biotechnology and medical care industry, announced its financial results for the first quarter of 2026, reporting a basic earnings per share of -NT$0.44, operating revenue of NT$82 million, and a net loss of NT$200 million.
What is the source and date?
PR Times: https://openapi.twse.com.tw/financial/twse-fin-4142-2026Q1 | March 1, 2026